Translate
Trisalus Life Sciences Inc.
About
Trisalus Life Sciences Inc. (NASDAQ:TLSI) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call
Apr 9 2026
TriSalus Life Sciences to Present New Data at the 2026 Society of Interventional Radiology Annual Scientific Meeting
Apr 7 2026
TriSalus Life Sciences Appoints Richard Marshall, M.D., as Chief Medical Officer
Mar 18 2026
TriSalus Life Sciences Announces Publication Demonstrating Enhanced Delivery and Immune Activation with Nelitolimod Delivered with Pressure-Enabled Drug Delivery in Liver Tumor Models
Mar 5 2026
TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance
Recent Videos
TriSalus Life Sciences, Inc. (0001826667) (Filer) #Shorts
Apr 11, 2026
My insight on TriSalus Life Sciences' latest executive hire
Apr 11, 2026
When “Good Enough” Bile Flow Saves a Life
Apr 10, 2026
Exploring TriSalus Life Sciences A Biotech Review
Apr 01, 2026
Financials
Revenue
$45.15 M
Market Cap
$250.57 M
EPS
-1.84